Sofinnova Investments, Inc. Protagonist Therapeutics, Inc Transaction History

Sofinnova Investments, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$23.34 - $36.08 $1.52 Million - $2.35 Million	65,184 Added 13.52%	547,441 $13 Million
Q4 2021 Feb 14, 2022	BUY	$17.63 - $37.1 $3.25 Million - $6.85 Million	184,548 Added 61.99%	482,257 $16.5 Million
Q3 2021 Nov 15, 2021	SELL	$12.95 - $49.69 $1.96 Million - $7.52 Million	-151,373 Reduced 33.71%	297,709 $5.28 Million
Q2 2021 Aug 16, 2021	SELL	$25.57 - $44.88 $5.26 Million - $9.24 Million	-205,818 Reduced 31.43%	449,082 $20.2 Million
Q1 2021 May 14, 2021	BUY	$19.02 - $31.15 $12.5 Million - $20.4 Million	654,900 New	654,900 $17 Million
Q4 2020 Feb 16, 2021	SELL	$18.49 - $25.13 $6.62 Million - $8.99 Million	-357,769 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$15.19 - $22.4 $481,598 - $710,192	31,705 Added 9.72%	357,769 $6.99 Million
Q2 2020 Aug 13, 2020	BUY	$6.19 - $18.84 $2.02 Million - $6.14 Million	326,064 New	326,064 $5.76 Million

212

59.1M

19K

107K

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $2.25B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.